Myelodysplastic syndrome with excess blasts-1

A myelodysplastic syndrome defined by 5-9% blasts in the bone marrow, and <5% blasts in the blood. Approximately 25% of cases progress to an acute leukemia. (WHO)

Also known as: MDS-EB-1, RAEB-1, RAEB-I, myelodysplastic syndrome with Excess blasts-1, refractory anaemia with excess blasts type 1, refractory anemia with excess blasts type 1

1854 clinical trials for this condition and its sub-types, 5 tagged with Myelodysplastic syndrome with excess blasts-1 itself.